During this special patient webinar, you will learn critical insights about new advances in minimally-invasive, robotic heart valve surgery. The featured speakers are Dr. Pavan Atluri, Director of Minimally Invasive and Robotic Cardiac Surgery, and Dr. Michael Ibrahim, Director of Reconstructive Valve Surgery, at Penn Medicine.

This is a “must read” paper for survivors and medical providers. It is exactly what is needed in the world of cancer survivorship–a comprehensive template for insuring that survivors get the care that they need. Download it, pass it on, place it in the hands of your doctors and caretakers.

This article describes the results of a study from the University of California San Francisco. It highlights one of the topics Dr. Micheal Stubblefield mentioned in his presentation at our conference. It comes from a paper that was published in the British Medical Journal Supportive and Palliative Care, July 2022. First author Steven W. Cheung, MD notes the marked incidence of hearing loss and tinnitus in survivors, owing to chemotherapy drugs that contained platinum as well as those that contained taxanes.